Ambrx Biopharma, Inc.
AMAMDelisted Mar 7, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001990550
Ambrx Biopharma, Inc. was delisted on Mar 7, 2024; its insiders filed their last Form 4 on Mar 7, 2024; 68 institutions reported holding it in 13F filings for Q4 2023, worth $912.7M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Ambrx Biopharma, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +12 vs. Q1 2023
- Shares held
- 47.9M
- +10.8M (+29.3%) vs. Q1 2023
- Total value
- $788.8M
- +$458.1M (+138.5%) vs. Q1 2023
- New holders
- 18
- 13 more added
- Sold out
- 6
- 8 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AMAM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 68 | $912.7M |
| Q3 2023 | 44 | $568.3M |
| Q2 2023 | 42 | $788.8M |
| Q1 2023 | 30 | $330.7M |
| Q4 2022 | 18 | $40.7M |
| Q3 2022 | 16 | $18.0M |
| Q2 2022 | 14 | $45.4M |
| Q1 2022 | 14 | $70.6M |
| Q4 2021 | 16 | $152.0M |
| Q3 2021 | 15 | $165.3M |
| Q2 2021 | 20 | $266.2M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Ambrx Biopharma, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BerganKDV Wealth Management, LLC | 100 | $1.65K | 0.00% | 00.0% | Unchanged |
| Aquatic Capital Management LLC | 400 | $7.00K | 0.00% | +400 | New |
| Bank of America Corp | 558 | $9.19K | 0.00% | +454+436.5% | Added |
| US Bancorp | 1,018 | $16.8K | 0.00% | +1,018 | New |
| Cutler Group LP | 1,800 | $29.0K | 0.01% | −1,300−41.9% | Reduced |
| Morgan Stanley | 3,070 | $50.5K | 0.00% | +3,028+7,209.5% | Added |
| Simplex Trading, LLC | 6,634 | $109.0K | 0.00% | −113,570−94.5% | Reduced |
| Virtus ETF Advisers LLC | 7,468 | $122.9K | 0.07% | +7,468 | New |
| Exchange Traded Concepts, LLC | 9,830 | $161.7K | 0.00% | +9,830 | New |
| QP Wealth Management, LLC | 12,670 | $208.5K | 0.33% | +12,670 | New |
| Belvedere Trading LLC | 13,872 | $228.3K | 0.07% | −2,936−17.5% | Reduced |
| Squarepoint Ops LLC | 16,480 | $271.3K | 0.00% | −1,031−5.9% | Reduced |
| Innovis Asset Management LLC | 16,826 | $277.0K | 0.10% | +16,826 | New |
| Jane Street Group, LLC | 17,538 | $288.7K | 0.00% | +17,538 | New |
| Apis Capital Advisors, LLC | 34,000 | $559.6K | 0.56% | +34,000 | New |
| Geode Capital Management, LLC | 39,438 | $649.1K | 0.00% | +39,438 | New |
| Alps Advisors Inc | 40,598 | $668.2K | 0.01% | +40,598 | New |
| Susquehanna International Group, LLP | 51,290 | $844.2K | 0.00% | −30,156−37.0% | Reduced |
| Manufacturers Life Insurance Company, The | 59,197 | $973.8K | 0.00% | +29,674+100.5% | Added |
| TD Asset Management Inc | 63,728 | $1.05M | 0.00% | +49,828+358.5% | Added |
| Schonfeld Strategic Advisors LLC | 98,600 | $1.62M | 0.01% | +20,400+26.1% | Added |
| Silverarc Capital Management, LLC | 100,000 | $1.65M | 0.56% | +100,000 | New |
| First Manhattan Co | 135,003 | $2.22M | 0.01% | +135,003 | New |
| Moore Capital Management, LP | 144,400 | $2.38M | 0.06% | +144,400 | New |
| HighVista Strategies LLC | 153,431 | $2.53M | 1.16% | +153,431 | New |
| JPMorgan Chase & Co | 157,858 | $2.60M | 0.00% | +157,858 | New |
| Ghost Tree Capital, LLC | 238,225 | $3.92M | 1.42% | −11,775−4.7% | Reduced |
| Millennium Management LLC | 285,716 | $4.70M | 0.00% | +274,727+2,500.0% | Added |
| Point72 Asset Management, L.P. | 349,938 | $5.76M | 0.02% | +349,938 | New |
| ExodusPoint Capital Management, LP | 477,558 | $7.86M | 0.09% | +458,061+2,349.4% | Added |
| Artal Group S.A. | 702,291 | $11.6M | 0.37% | 00.0% | Unchanged |
| Citadel Advisors LLC | 727,022 | $12.0M | 0.01% | +19,889+2.8% | Added |
| Holocene Advisors, LP | 913,754 | $15.0M | 0.07% | +913,754 | New |
| Price T Rowe Associates Inc | 929,317 | $15.3M | 0.00% | +718,690+341.2% | Added |
| Paradigm Biocapital Advisors LP | 1,650,499 | $27.2M | 2.20% | +1,650,499 | New |
| FMR LLC | 2,210,618 | $36.4M | 0.00% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 2,269,000 | $37.3M | 0.22% | +1,908,000+528.5% | Added |
| VR Adviser, LLC | 2,484,960 | $40.9M | 6.54% | −813,617−24.7% | Reduced |
| Commodore Capital LP | 3,175,000 | $52.3M | 5.87% | −1,628,447−33.9% | Reduced |
| D. E. Shaw & Co., Inc. | 4,015,908 | $66.1M | 0.10% | +82,356+2.1% | Added |
| Cormorant Asset Management, LP | 9,616,155 | $158.3M | 9.01% | +1,116,155+13.1% | Added |
| Darwin Global Management, Ltd. | 16,688,636 | $274.7M | 44.91% | +5,384,063+47.6% | Added |
| Fosun International Ltd | 0 | $0 | 0.00% | −249,190−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −57,268−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −56,868−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −20,440−100.0% | Sold out |
| Tocqueville Asset Management L.P. | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,345−100.0% | Sold out |